6090 — Human Metabolome Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- ¥4bn
- ¥3bn
- ¥1bn
- 53
- 38
- 27
- 29
Annual cashflow statement for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 15 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -591 | -24.5 | 50.9 | 262 | 237 |
| Depreciation | |||||
| Non-Cash Items | 116 | 32.8 | 37.3 | -27.8 | 4.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 129 | 128 | -178 | 25 | -37.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -265 | 184 | -34.2 | 324 | 285 |
| Capital Expenditures | -152 | -34.8 | -27.9 | -146 | -117 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 97.6 | -0.095 | 1.88 | -6.2 | 0.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -54.8 | -34.9 | -26 | -152 | -117 |
| Financing Cash Flow Items | -0.001 | -0.001 | — | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.07 | 22.1 | 86.2 | 80.5 | -13.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -313 | 171 | 26 | 260 | 152 |